I was looking at this - an inexperienced limited assessment.
EMV - one marketable device - mobile medical imaging for ambulances, flying doc. No FDA approval to date. Market cap $218.6 million SP $2.99.
MX1 Four marketable devices, FDA approval for medical imaging. Market Cap $142.6 SP .31c.
There will be other factors I have not considered but the EMV comparison increases my confidence that MX1 is undervalued and is due a rerate.
Regards
I was looking at this - an inexperienced limited assessment. EMV...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
